Literature DB >> 23396451

Ketone body metabolism and cardiovascular disease.

David G Cotter1, Rebecca C Schugar, Peter A Crawford.   

Abstract

Ketone bodies are metabolized through evolutionarily conserved pathways that support bioenergetic homeostasis, particularly in brain, heart, and skeletal muscle when carbohydrates are in short supply. The metabolism of ketone bodies interfaces with the tricarboxylic acid cycle, β-oxidation of fatty acids, de novo lipogenesis, sterol biosynthesis, glucose metabolism, the mitochondrial electron transport chain, hormonal signaling, intracellular signal transduction pathways, and the microbiome. Here we review the mechanisms through which ketone bodies are metabolized and how their signals are transmitted. We focus on the roles this metabolic pathway may play in cardiovascular disease states, the bioenergetic benefits of myocardial ketone body oxidation, and prospective interactions among ketone body metabolism, obesity, metabolic syndrome, and atherosclerosis. Ketone body metabolism is noninvasively quantifiable in humans and is responsive to nutritional interventions. Therefore, further investigation of this pathway in disease models and in humans may ultimately yield tailored diagnostic strategies and therapies for specific pathological states.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23396451      PMCID: PMC3625904          DOI: 10.1152/ajpheart.00646.2012

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  241 in total

1.  The nitrated proteome in heart mitochondria of the db/db mouse model: characterization of nitrated tyrosine residues in SCOT.

Authors:  Yuan Wang; Fuli Peng; Wei Tong; Haidan Sun; Ningzhi Xu; Siqi Liu
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

2.  Obligate role for ketone body oxidation in neonatal metabolic homeostasis.

Authors:  David G Cotter; D André d'Avignon; Anna E Wentz; Mary L Weber; Peter A Crawford
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

3.  Identification of lysine succinylation as a new post-translational modification.

Authors:  Zhihong Zhang; Minjia Tan; Zhongyu Xie; Lunzhi Dai; Yue Chen; Yingming Zhao
Journal:  Nat Chem Biol       Date:  2010-12-12       Impact factor: 15.040

4.  SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; Lan Hua; Kristin E Dittenhafer-Reed; Bjoern Schwer; David B Lombard; Yu Li; Jakob Bunkenborg; Frederick W Alt; John M Denu; Matthew P Jacobson; Eric Verdin
Journal:  Cell Metab       Date:  2010-12-01       Impact factor: 27.287

5.  Short-chain fatty acids in germfree mice and rats.

Authors:  T Høverstad; T Midtvedt
Journal:  J Nutr       Date:  1986-09       Impact factor: 4.798

6.  Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.

Authors:  Tadahiro Shimazu; Matthew D Hirschey; John Newman; Wenjuan He; Kotaro Shirakawa; Natacha Le Moan; Carrie A Grueter; Hyungwook Lim; Laura R Saunders; Robert D Stevens; Christopher B Newgard; Robert V Farese; Rafael de Cabo; Scott Ulrich; Katerina Akassoglou; Eric Verdin
Journal:  Science       Date:  2012-12-06       Impact factor: 47.728

7.  Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages.

Authors:  P Newsholme; R Curi; S Gordon; E A Newsholme
Journal:  Biochem J       Date:  1986-10-01       Impact factor: 3.857

8.  Effects of insulin on ketogenesis following fasting in lean and obese men.

Authors:  Maarten R Soeters; Hans P Sauerwein; Linda Faas; Martijn Smeenge; Marinus Duran; Ronald J Wanders; An F Ruiter; Mariëtte T Ackermans; Eric Fliers; Sander M Houten; Mireille J Serlie
Journal:  Obesity (Silver Spring)       Date:  2009-02-19       Impact factor: 5.002

9.  Liver-specific silencing of the human gene encoding succinyl-CoA: 3-ketoacid CoA transferase.

Authors:  Kenji E Orii; Toshiyuki Fukao; Xiang-Qian Song; Grant A Mitchell; Naomi Kondo
Journal:  Tohoku J Exp Med       Date:  2008-07       Impact factor: 1.848

10.  Innate immunity and intestinal microbiota in the development of Type 1 diabetes.

Authors:  Li Wen; Ruth E Ley; Pavel Yu Volchkov; Peter B Stranges; Lia Avanesyan; Austin C Stonebraker; Changyun Hu; F Susan Wong; Gregory L Szot; Jeffrey A Bluestone; Jeffrey I Gordon; Alexander V Chervonsky
Journal:  Nature       Date:  2008-09-21       Impact factor: 49.962

View more
  137 in total

1.  Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth.

Authors:  Siyuan Xia; Ruiting Lin; Lingtao Jin; Liang Zhao; Hee-Bum Kang; Yaozhu Pan; Shuangping Liu; Guoqing Qian; Zhiyu Qian; Evmorfia Konstantakou; Baotong Zhang; Jin-Tang Dong; Young Rock Chung; Omar Abdel-Wahab; Taha Merghoub; Lu Zhou; Ragini R Kudchadkar; David H Lawson; Hanna J Khoury; Fadlo R Khuri; Lawrence H Boise; Sagar Lonial; Benjamin H Lee; Brian P Pollack; Jack L Arbiser; Jun Fan; Qun-Ying Lei; Jing Chen
Journal:  Cell Metab       Date:  2017-01-12       Impact factor: 27.287

Review 2.  Heart failure and loss of metabolic control.

Authors:  Zhao V Wang; Dan L Li; Joseph A Hill
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

Review 3.  A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.

Authors:  Ashish Gupta; Brian Houston
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

Review 4.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

5.  Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.

Authors:  David G Cotter; Baris Ercal; Xiaojing Huang; Jamison M Leid; D André d'Avignon; Mark J Graham; Dennis J Dietzen; Elizabeth M Brunt; Gary J Patti; Peter A Crawford
Journal:  J Clin Invest       Date:  2014-10-27       Impact factor: 14.808

6.  Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.

Authors:  David G Cotter; Baris Ercal; D André d'Avignon; Dennis J Dietzen; Peter A Crawford
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-05-27       Impact factor: 4.310

7.  Endogenous siderophore 2,5-dihydroxybenzoic acid deficiency promotes anemia and splenic iron overload in mice.

Authors:  Zhuoming Liu; Alieta Ciocea; L Devireddy
Journal:  Mol Cell Biol       Date:  2014-04-28       Impact factor: 4.272

8.  Elevated sensitivity of macrosteatotic hepatocytes to hypoxia/reoxygenation stress is reversed by a novel defatting protocol.

Authors:  Nir I Nativ; Gabriel Yarmush; Ashley So; Jeffery Barminko; Timothy J Maguire; Rene Schloss; Francois Berthiaume; Martin L Yarmush
Journal:  Liver Transpl       Date:  2014-07-02       Impact factor: 5.799

Review 9.  Renal, metabolic and cardiovascular considerations of SGLT2 inhibition.

Authors:  Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Nat Rev Nephrol       Date:  2016-12-12       Impact factor: 28.314

Review 10.  An update on cell intrinsic negative regulators of the NLRP3 inflammasome.

Authors:  Barun Poudel; Prajwal Gurung
Journal:  J Leukoc Biol       Date:  2018-01-26       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.